A decreased expression of FasR was found in CD4+ CCR5+ T cells in relapsing-remitting (RR)-MS patients suggesting that the FasR contributes to the pathogenesis of MS by prolonging survival of autoreactive lymphocytes and enhancing migration of T cells into the CNS [12]. Here, CCR5 is linked to myeloid sarcoma.